Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-580-7 | CAS number: 64-19-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Non-human information
In vitro data
The key studies are considered to be bacterial mutation assays (Zeiger et al., 1992; Ishidate et al., 1984) and a mammalian cell cytogenetic assay (Morita et al., 1990). These are two recognised core assay types for investigating mutation in vitro.
Glacial acetic acid (99.7 %) was tested in the Salmonella mutation assay using four strains of Salmonella typhimurium (TA1537, TA97, TA98, TA100) with and without metabolic activation from hamster and rat liver S9 (10% and 30% S9). The pre-incubation assay was used with a 20 minute pre-incubation time before plating, and with doses up to 10mg/plate (Zeiger et al., 1992). A similar evaluation of glacial acetic acid including additional Salmonella strains was undertaken in a pre-incubation assay (20 minute), with and without rat liver S9, and up to doses of 10 mg/plate. Salmonella strains TA1535, TA1537, TA92, TA98, TA100, and TA94 were used. Both assays gave negative results for acetic acid. Other evaluations in bacterial genotoxicity assays have given confirmatory negative results, including mutagenicity assays and an SOS assay, but one positive result was reported in 1951 for a non-guideline study of streptomycin dependence in strains of E coli. Contradictory results have been reported in bacterial DNA repair assays (EU DAR, 2008).
Overall, the data indicate that acetic acid is not mutagenic in bacterial test systems.
Acetic acid has been examined for cytogenetic activity in the absence and presence of S9 in Chinese hamster ovary K1 cells (Morita et al., 1990). The evaluation included an examination of the relationship between the pH of the medium and clastogenic activity. A dose-dependent increase in chromosomal aberrations was observed in CHO cells exposed to acetic acid, beginning at a concentration of 10 mM in the absence of S9 and at 8 mM in the presence of S9. These concentrations were close to the cytotoxic limit at which cells could no longer be evaluated. This activity was removed when the pH of the medium was maintained near neutral through the use of media with increased buffering capacity, or by neutralisation with sodium hydroxide. This activity, observed at or near the limit dose for this assay type (10 mM), and which is removed when the pH is maintained at near neutral, is considered to be a function of the pH change induced by acetic acid at very high concentrations, and not due to genotoxicity of the chemical itself. This is supported by negative findings in other cytogenetic assays using standard dose levels, or positive results only when the pH is once again reduced through excessively high concentrations of acetic acid (EU DAR, 2008).
It is concluded that acetic acid has no significant clastogenic activity in vitro.
Small increases in sister chromatid exchanges were observed in isolated human lymphocytes treated in vitro but only under the same conditions of high acetic acid concentrations where a reduction in pH was seen (EU DAR, 2008). Acetic acid is considered to have no significant cytogenetic activity under conditions of biological relevance.
Acetic acid has not been examined in an in vitro mammalian cell gene mutation assay. However, there are data available that indicate that acetic acid would not show any significant genotoxic activity in this assay. Acetic acid has been examined in a number of studies with different endpoints and concluded to have no significant genotoxic activity, including bacterial mutation, SOS chromotest, and cytogenetic assays in mammalian cells. In the cytogenetic assays (chromosomal damage and sister chromatid exchange), effects were only seen at very high doses (non-physiological doses and ones exceeding the guideline limit doses for the assays) and these were due to the induced pH changes in the cell culture systems. These data indicate that were acetic acid to be examined in a mammalian cell gene mutation assay such as the L5178Y TK+/- assay, it would show no genotoxic activity at standard dose levels, but would follow the cytogenetic assays and at excessively high doses, the pH of the cell culture system would be altered, and effects may be seen. However, any such effects would be (as with the cytogenetic assays), of no relevance for any meaningful hazard assessment of acetic acid. This phenomenon of irrelevant effects at reduced pH levels in mammalian cell gene mutation assays has already been reported (Cifone et al, 1987) [see comment in table above], including reference to the effect being induced by several short chained aliphatic acids.
Acetic acid has been shown to have no significant genotoxic activity in a number of endpoints, and acetate is a normal component of cellular metabolism. It is considered that there are sufficient data to be able conclude that acetic acid has no significant genotoxic activity in vitro, and that the conduct of a mammalian cell gene mutation assay would not change this conclusion.
Acetic anhydride hydrolyses rapidly in aqueous media to release 2 molecules of acetic acid per mole of acetic anhydride and so provides an equivalent test material exposure to testing using acetic acid.
In vivo data
No data from in vivo regulatory studies for genotoxicity are available.
An abstract containing limited details and data reported that acetic acid applied dermally in acetone at doses of 25 and 30 mg produced increased mutant frequencies in the skin of transgenic mice (MUTA™mouse) killed on day 7 postdose (EU DAR, 2008). However, these doses also caused focal ulceration and eschar formation. No increase in mutations was seen at lower doses inducing mild irritation. It is likely that any mutagenic effects were secondary to the severe toxicity induced. These data are considered insufficient to indicate any significant genotoxic activity for acetic acid in vivo.
Acetate is a systemic metabolite of acetic anhydride. Since acetic anhydride did not cause any substantial increase in the incidence of micronucleated immature erythrocytes or any substantial decrease in the proportion of immature erythrocytes, it is concluded that acetic anhydride and its systemic metabolite acetate, did not show any evidence of causing chromosome damage or bone marrow cell toxicity following subchronic inhalation exposure of rats in this in vivo test procedure (HRC, 1996).
Human information
There is no information indicating any adverse effects of acetic acid.
Summary and Discussion of Mutagenicity
Acetic acid has been examined for mutagenicity in vitro in recognised core assays. It has shown negative results for mutagenicity in vitro, and with no indications for likely mutagenicity in vivo. It is concluded that the available data indicate that acetic acid has no significant genotoxicity. The available data from in vitro studies suggest that at excessive and unphysiological concentrations of acetic acid, the pH of the test system is significantly reduced and positive results can be induced as a result of this. However, these results are at doses exceeding the limit dose for the assays, which cause circumstances that are now accepted in the literature as being artificial and of no value for contributing to an evaluation of the genotoxicity of a chemical (EU DAR, 2008). There are limited data indicating that this may also be the case in vivo.
It is concluded that the available data indicate that acetic acid has no significant genotoxic activity.
Citation:
HSE(2002): Acetic anhydride Risk Assessment Document. EH72/16. ISBN 0 7176 2364 5
Short description of key information:
The available data indicate that acetic acid has no significant genotoxic activity.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Available data indicate no genotoxic activity, therefore acetic acid does not warrant classification for genotoxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.